Evidence map›Paper›PMID 29216246›Full record

ArticlePloS one2017

Draft genome sequence of Actinotignum schaalii DSM 15541T: Genetic insights into the lifestyle, cell fitness and virulence.

Atteyet F Yassin, Stefan Langenberg, Marcel Huntemann, Alicia Clum, Manoj Pillay, Krishnaveni Palaniappan, Neha Varghese, Natalia Mikhailova, Supratim Mukherjee, T B K Reddy and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Heliyon · 2024
    Article
  5. Case report: A rare case of skin abscess caused by coinfection ofFrontiers in cellular and infection microbiology · 2024
    Article
  6. Article
  7. Article
  8. Germs · 2022
    Article
  9. Microorganisms · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Atteyet F YassinInstitut für medizinische Mikrobiologie und Immunologie der Universität Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-5711-4103
Stefan LangenbergKlinik und Poliklinik für Hals-Nasen-Ohrenheilkunde/Chirurgie, Bonn, Germany.
Marcel HuntemannDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Alicia ClumDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Manoj PillayDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Krishnaveni PalaniappanDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Neha VargheseKlinik und Poliklinik für Hals-Nasen-Ohrenheilkunde/Chirurgie, Bonn, Germany.
Natalia MikhailovaDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Supratim MukherjeeDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
T B K ReddyDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Chris DaumDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Nicole ShapiroDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Natalia IvanovaDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Tanja WoykeDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Nikos C KyrpidesDepartment of Energy Joint Genome Institute, Genome Biology Program, Walnut Creek, CA, United States of America.
Joint Genome Institute · USKlinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The permanent draft genome sequence of Actinotignum schaalii DSM 15541T is presented. The annotated genome includes 2,130,987 bp, with 1777 protein-coding and 58 rRNA-coding genes. Genome sequence analysis revealed absence of genes encoding for: components of the PTS systems, enzymes of the TCA cycle, glyoxylate shunt and gluconeogensis. Genomic data revealed that A. schaalii is able to oxidize carbohydrates via glycolysis, the nonoxidative pentose phosphate and the Entner-Doudoroff pathways. Besides, the genome harbors genes encoding for enzymes involved in the conversion of pyruvate to lactate, acetate and ethanol, which are found to be the end products of carbohydrate fermentation. The genome contained the gene encoding Type I fatty acid synthase required for de novo FAS biosynthesis. The plsY and plsX genes encoding the acyltransferases necessary for phosphatidic acid biosynthesis were absent from the genome. The genome harbors genes encoding enzymes responsible for isoprene biosynthesis via the mevalonate (MVA) pathway. Genes encoding enzymes that confer resistance to reactive oxygen species (ROS) were identified. In addition, A. schaalii harbors genes that protect the genome against viral infections. These include restriction-modification (RM) systems, type II toxin-antitoxin (TA), CRISPR-Cas and abortive infection system. A. schaalii genome also encodes several virulence factors that contribute to adhesion and internalization of this pathogen such as the tad genes encoding proteins required for pili assembly, the nanI gene encoding exo-alpha-sialidase, genes encoding heat shock proteins and genes encoding type VII secretion system. These features are consistent with anaerobic and pathogenic lifestyles. Finally, resistance to ciprofloxacin occurs by mutation in chromosomal genes that encode the subunits of DNA-gyrase (GyrA) and topisomerase IV (ParC) enzymes, while resistant to metronidazole was due to the frxA gene, which encodes NADPH-flavin oxidoreductase.

Indexed as

Genome, BacterialActinomycetaceaeAnti-Bacterial AgentsCarbohydrate MetabolismDrug Resistance, MicrobialFermentationGenotypeLipid MetabolismOxidative StressPhenotypePhylogenyPyruvic AcidAnti-Bacterial AgentsPyruvic Acid

Identifiers

PMID29216246
PMCPMC5720513
OpenAlexW2774937115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.